Gerald J. McDougall's most recent trade in NeuBase Therapeutics Inc was a trade of 37,600 Stock option (right to buy) done . Disclosure was reported to the exchange on Sept. 9, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NeuBase Therapeutics Inc | Gerald J. McDougall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2022 | 37,600 | 37,600 | - | - | Stock option (right to buy) | |
| NeuBase Therapeutics Inc | Gerald J. McDougall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2021 | 38,135 | 38,135 | - | - | Stock option (right to buy) | |
| NeuBase Therapeutics Inc | Gerald J. McDougall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 92,219 | 92,219 | - | - | Employee stock option (right to buy) |